PROM1 and melanoma: The involvement of the CD133 protein in the maintenance of melanoma stemness properties and drug resistance is mediated through its C-terminal domain, which contains tyrosine binding sites located on tyrosine 828 (Tyr828) and tyrosine 852 (Tyr852) residues [9,116].